X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6336) 6336
Book Review (1440) 1440
Publication (624) 624
Book Chapter (13) 13
Conference Proceeding (13) 13
Magazine Article (3) 3
Dissertation (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5170) 5170
humans (4874) 4874
plus ribavirin (3214) 3214
antiviral agents - therapeutic use (2838) 2838
gastroenterology & hepatology (2833) 2833
hepatitis c (2818) 2818
hepatitis c, chronic - drug therapy (2743) 2743
male (2743) 2743
female (2653) 2653
middle aged (2377) 2377
adult (2181) 2181
hepatitis c virus (2010) 2010
hepacivirus - genetics (1819) 1819
ribavirin - therapeutic use (1803) 1803
treatment outcome (1784) 1784
ribavirin (1755) 1755
drug therapy, combination (1727) 1727
interferon (1710) 1710
virus-infection (1665) 1665
interferon-alpha - therapeutic use (1645) 1645
genotype (1601) 1601
infectious diseases (1293) 1293
hepatitis (1232) 1232
recombinant proteins (1214) 1214
therapy (1211) 1211
infection (1154) 1154
virology (1144) 1144
hepatitis c - drug therapy (1138) 1138
hepatitis c, chronic - virology (1090) 1090
aged (1074) 1074
sustained virological response (1068) 1068
hepacivirus - drug effects (1029) 1029
antiviral agents - administration & dosage (1013) 1013
polyethylene glycols - therapeutic use (993) 993
combination therapy (953) 953
peginterferon alpha-2a (913) 913
health aspects (879) 879
antiviral agents - adverse effects (878) 878
initial treatment (877) 877
pharmacology & pharmacy (875) 875
pegylated interferon (864) 864
hcv (858) 858
viral load (855) 855
interferon-alpha-2b plus ribavirin (842) 842
chronic hepatitis-c (802) 802
ribavirin - administration & dosage (793) 793
biological response modifiers (777) 777
care and treatment (764) 764
antiviral agents (719) 719
randomized-trial (706) 706
interferon-alpha - administration & dosage (701) 701
hepatitis c, chronic - complications (669) 669
cirrhosis (666) 666
drug therapy (660) 660
rna, viral - blood (657) 657
chronic hepatitis c (635) 635
liver (621) 621
analysis (601) 601
hiv (588) 588
antiviral therapy (572) 572
hepatocellular-carcinoma (569) 569
virus diseases (567) 567
human-immunodeficiency-virus (554) 554
immunology (552) 552
hiv infections - complications (542) 542
peginterferon (538) 538
ribavirin - adverse effects (535) 535
genetic aspects (526) 526
infections (522) 522
interferon-alpha - adverse effects (522) 522
combination (521) 521
retrospective studies (521) 521
peginterferon alpha-2b (515) 515
alpha-2b plus ribavirin (510) 510
risk factors (507) 507
hepacivirus - isolation & purification (496) 496
hepatitis c - virology (495) 495
alpha-2a plus ribavirin (487) 487
microbiology (472) 472
medicine, general & internal (470) 470
antiviral agents - pharmacology (463) 463
genotype 1 infection (461) 461
virus (448) 448
gastroenterology and hepatology (447) 447
polyethylene glycols - administration & dosage (437) 437
virological response (436) 436
genotypes (431) 431
interferon-alpha (430) 430
abridged index medicus (426) 426
fibrosis (425) 425
recombinant proteins - therapeutic use (418) 418
hepatitis c - complications (416) 416
telaprevir (410) 410
treatment-naive patients (404) 404
prospective studies (402) 402
prevalence (397) 397
time factors (396) 396
viruses (395) 395
interferons - therapeutic use (393) 393
liver cirrhosis (392) 392
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6093) 6093
French (84) 84
Spanish (65) 65
German (44) 44
Japanese (21) 21
Russian (12) 12
Korean (6) 6
Turkish (6) 6
Portuguese (4) 4
Hungarian (3) 3
Polish (3) 3
Serbian (3) 3
Czech (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/2016, Volume 44, Issue 9, pp. 946 - 956
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1594 - 1603
In this trial in previously untreated patients with HCV genotype 1 infection and no cirrhosis, high rates of sustained response were achieved with three new... 
TRIAL | MEDICINE, GENERAL & INTERNAL | PLUS SOFOSBUVIR | C VIRUS-INFECTION | GENOTYPE 1 INFECTION | DACLATASVIR | SIMEPREVIR TMC435 | HEPATITIS-C | INTERFERON-FREE | TREATMENT-NAIVE PATIENTS | PHASE 2B | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Viral Load | Young Adult | Ritonavir - adverse effects | Ritonavir - therapeutic use | Adult | Female | Double-Blind Method | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Uracil - therapeutic use | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adolescent | Sulfonamides - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Drug Combinations | Uracil - analogs & derivatives | Dosage and administration | Research | Drug therapy, Combination | Hepatitis C | Drug therapy | Ribavirin | Ritonavir | Body weight | Diarrhea | Infections | Nausea | Proteinase inhibitors | Pruritus | Drug resistance | Patients | Genotype & phenotype | Cirrhosis | Sleep disorders | Hepatitis | Asthenia | Hemoglobin | Interferon | Drug dosages | Genotypes | Index Medicus | Abridged Index Medicus
Journal Article
JAMA, ISSN 0098-7484, 03/2015, Volume 313, Issue 12, pp. 1223 - 1231
Journal Article
JAMA, ISSN 0098-7484, 08/2013, Volume 310, Issue 8, pp. 804 - 811
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Haemophilia, ISSN 1351-8216, 2016, Volume 22, Issue 5, pp. 692 - 699
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 136, Issue 5, pp. 1618 - 1628.e2
Journal Article